Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00752843 · ClinicalTrials.gov registry record · Phase 1
A Phase I Study to Determine the Effect of Mifepristone on the Pharmacokinetics of Fluvastatin in Healthy Volunteers
A Phase 1 study, sponsored by Corcept Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00752843 is a Phase 1 study that has completed, run by Corcept Therapeutics. The registered enrollment target is 20 participants.
The verdict
NCT00752843, a Phase 1 study, has completed, sponsored by Corcept Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is to determine the effect of single and multiple oral doses of mifepristone on the pharmacokinetics of a single oral dose of fluvastatin administered to healthy volunteers.
Interventions
- DRUG mifepristone + fluvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-09 |
| Est. Completion | 2008-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00752843
The ClinicalTrials.gov registry entry for NCT00752843 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corcept Therapeutics, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which mifepristone + fluvastatin is the first listed.
NCT00752843 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00752843 about?
NCT00752843 is a clinical study titled "A Phase I Study to Determine the Effect of Mifepristone on the Pharmacokinetics of Fluvastatin in Healthy Volunteers". This study is to determine the effect of single and multiple oral doses of mifepristone on the pharmacokinetics of a single oral dose of fluvastatin administered to healthy volunteers.
What is the current status of trial NCT00752843?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2008-09. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00752843?
The interventions under investigation include: mifepristone + fluvastatin (DRUG).
Who is sponsoring clinical trial NCT00752843?
This trial is sponsored by Corcept Therapeutics, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.